Cdk5: multitasking between physiological and pathological conditions.

作者: Joao P. Lopes , Paula Agostinho

DOI: 10.1016/J.PNEUROBIO.2011.03.006

关键词:

摘要: Abstract Cyclin-dependent kinase 5 (Cdk5) is a peculiar proline-directed serine/threonine kinase. Unlike the other members of Cdk family, Cdk5 not directly involved in cell cycle regulation, being normally associated with neuronal processes such as migration, cortical layering and synaptic plasticity. This present mainly post-mitotic neurons its activity tightly regulated by interaction specific activators, p35 p39. Despite pivotal role CNS development, dysregulation has been implicated different pathologies, Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson's (PD) and, most recently, prion-related encephalopathies (PRE). In these neurodegenerative conditions, overactivation relocalization occurs upon association p25, truncated form normal activator p35. switching will cause shift phosphorylative pattern Cdk5, an alteration both targets activity, ultimately leading to demise. AD PRE, two disorders that share clinical neuropathological features, linking event between major markers: amyloid plaques, tau hyperphosphorylation loss. Moreover, this was shown be abortive re-entry, feature recently proposed possible step apoptosis mechanism several neurological diseases. review focuses on neurons, namely regulation cytoskeletal dynamics, function survival, physiological pathological highlighting relevance main mechanisms neurodegeneration brain pathologies.

参考文章(264)
Richard A. Armstrong, Plaques and tangles and the pathogenesis of Alzheimer’s disease Folia Neuropathologica. ,vol. 44, pp. 1- 11 ,(2006)
K.N. GREEN, I.F. SMITH, F.M. LAFERLA, Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models. Sub-cellular biochemistry. ,vol. 45, pp. 507- 521 ,(2007) , 10.1007/978-1-4020-6191-2_19
Takeshi Harada, Takaya Morooka, Satoshi Ogawa, Eisuke Nishida, ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1 Nature Cell Biology. ,vol. 3, pp. 453- 459 ,(2001) , 10.1038/35074516
Amy KY Fu, Wing-Yu Fu, Janet Cheung, Karl WK Tsim, Fanny CF Ip, Jerry H Wang, Nancy Y Ip, None, Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nature Neuroscience. ,vol. 4, pp. 374- 381 ,(2001) , 10.1038/86019
Edward C Gilmore, Toshio Ohshima, André M Goffinet, Ashok B Kulkarni, Karl Herrup, None, Cyclin-Dependent Kinase 5-Deficient Mice Demonstrate Novel Developmental Arrest in Cerebral Cortex The Journal of Neuroscience. ,vol. 18, pp. 6370- 6377 ,(1998) , 10.1523/JNEUROSCI.18-16-06370.1998
M P McKinley, R K Meyer, L Kenaga, F Rahbar, R Cotter, A Serban, S B Prusiner, Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. Journal of Virology. ,vol. 65, pp. 1340- 1351 ,(1991) , 10.1128/JVI.65.3.1340-1351.1991
Susi Keck, Robert Nitsch, Tilman Grune, Oliver Ullrich, Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. Journal of Neurochemistry. ,vol. 85, pp. 115- 122 ,(2003) , 10.1046/J.1471-4159.2003.01642.X
Della C. David, Robert Layfield, Louise Serpell, Yolanda Narain, Michel Goedert, Maria Grazia Spillantini, Proteasomal degradation of tau protein. Journal of Neurochemistry. ,vol. 83, pp. 176- 185 ,(2002) , 10.1046/J.1471-4159.2002.01137.X
Shin-ichi Hisanaga, Ryo Endo, Regulation and role of cyclin-dependent kinase activity in neuronal survival and death Journal of Neurochemistry. ,vol. 115, pp. 1309- 1321 ,(2010) , 10.1111/J.1471-4159.2010.07050.X
Hideki Shimura, Nobutaka Hattori, Shin-ichiro Kubo, Yoshikuni Mizuno, Shuichi Asakawa, Shinsei Minoshima, Nobuyoshi Shimizu, Kazuhiro Iwai, Tomoki Chiba, Keiji Tanaka, Toshiaki Suzuki, Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nature Genetics. ,vol. 25, pp. 302- 305 ,(2000) , 10.1038/77060